We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$777M
AUM Growth
-$10.7M
Cap. Flow
-$2.88M
Cap. Flow %
-0.37%
Top 10 Hldgs %
22.01%
Holding
267
New
2
Increased
69
Reduced
89
Closed
10

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$1.46M
2
AGN
Allergan plc
AGN
+$662K
3
DIS icon
Walt Disney
DIS
+$472K
4
WY icon
Weyerhaeuser
WY
+$319K
5
ATW
Atwood Oceanics
ATW
+$311K

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$2.13M
2
FRX
FOREST LABORATORIES INC
FRX
+$880K
3
ABBV icon
AbbVie
ABBV
+$539K
4
NLSN
Nielsen Holdings plc
NLSN
+$388K
5
GXC icon
State Street SPDR S&P China ETF
GXC
+$361K

Sector Composition

Rank Sector Weight
1 Healthcare 18.02%
2 Miscellaneous 14.73%
3 Industrials 14.1%
4 Technology 12.24%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MON
26
DELISTED
Monsanto Co
MON
$8.32M 1.07%
73,945
+246
+0.3% +$28.8K
RTX icon
27
RTX Corp
RTX
$264B
$8.31M 1.07%
125,104
-1,244
-1% -$85.3K
TDC icon
28
Teradata
TDC
$2.78B
$8.07M 1.04%
192,572
-400
-0.2% -$17.2K
NKE icon
29
Nike
NKE
$54B
$7.45M 0.96%
166,994
-828
-0.5% -$32.8K
ECL icon
30
Ecolab
ECL
$76.8B
$7.28M 0.94%
63,410
+203
+0.3% +$22.9K
PX
31
DELISTED
Praxair Inc
PX
$7.26M 0.93%
56,293
-77
-0.1% -$10.1K
AFL icon
32
Aflac
AFL
$58.8B
$7M 0.9%
240,284
-2,260
-0.9% -$68.8K
IBM icon
33
IBM
IBM
$236B
$6.71M 0.86%
37,001
-126
-0.3% -$23K
PH icon
34
Parker-Hannifin
PH
$116B
$6.35M 0.82%
55,624
– –
MRK icon
35
Merck
MRK
$354B
$6.13M 0.79%
108,318
-367
-0.3% -$20.6K
MCD icon
36
McDonald's
MCD
$180B
$6.06M 0.78%
63,871
-3,085
-5% -$294K
PCL
37
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$6.02M 0.77%
154,293
-3,277
-2% -$137K
TEVA icon
38
Teva Pharmaceuticals
TEVA
$45.4B
$6M 0.77%
111,526
-76
-0.1% -$4.03K
ZBRA icon
39
Zebra Technologies
ZBRA
$16.2B
$5.87M 0.76%
82,670
-536
-0.6% -$41.8K
DLTR icon
40
Dollar Tree
DLTR
$21.4B
$5.82M 0.75%
103,750
+411
+0.4% +$22.7K
PM icon
41
Philip Morris
PM
$301B
$5.75M 0.74%
68,922
-290
-0.4% -$24.5K
MMM icon
42
3M
MMM
$84.7B
$5.68M 0.73%
47,993
-532
-1% -$64K
VEU icon
43
Vanguard FTSE All-World ex-US ETF
VEU
$69B
$5.68M 0.73%
115,375
-364
-0.3% -$18.8K
ABBV icon
44
AbbVie
ABBV
$464B
$5.57M 0.72%
96,449
-9,712
-9% -$539K
SYK icon
45
Stryker
SYK
$108B
$5.4M 0.7%
66,905
-150
-0.2% -$12.3K
DHR icon
46
Danaher
DHR
$146B
$5.4M 0.7%
105,776
+408
+0.4% +$21K
FRC
47
DELISTED
First Republic Bank
FRC
$5.21M 0.67%
105,427
+3,749
+4% +$184K
NEE icon
48
NextEra Energy
NEE
$170B
$5.11M 0.66%
217,724
-260
-0.1% -$6.28K
CVX icon
49
Chevron
CVX
$425B
$5.01M 0.64%
41,973
+29
+0.1% +$3.7K
MSFT icon
50
Microsoft
MSFT
$3.71T
$4.99M 0.64%
107,537
-315
-0.3% -$14.1K
1
2
3 4 5

Similar funds

MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.65B AUM 184.75% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Boston Family Office's Q3 2014 Portfolio in Review

As of Q3 2014, Boston Family Office held 267 positions worth $777M, down 1.4% from $788M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 4.5%. Boston Family Office opened 2 new positions and exited 10, leaving the 267-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Industrials.

  • Boston Family Office's largest Q3 2014 buy was Allergan plc: 2,957 shares worth $713K.
  • Boston Family Office added most to Verizon in Q3 2014, an estimated $1.46M increase.
  • Boston Family Office's biggest Q3 2014 reduction was AbbVie, cutting an estimated $539K.
  • Boston Family Office fully exited Meridian Bioscience Inc in Q3 2014, selling an estimated $2.13M.
  • Boston Family Office's ten largest holdings make up 22% of its $777M portfolio in Q3 2014.
  • Boston Family Office opened 2 new positions and closed 10 in Q3 2014.
  • Boston Family Office's portfolio value fell 1.4% quarter-over-quarter to $777M.

Based on Boston Family Office's 13F filing for Q3 2014, filed 31 Oct 2014.